Skip Navigation

Cardiovascular Research 1998 37(3):586-600; doi:10.1016/S0008-6363(97)00233-2
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bierhaus, A.
Right arrow Articles by Nawroth, P. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bierhaus, A.
Right arrow Articles by Nawroth, P. P
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept

Angelika Bierhaus, Marion A Hofmann, Reinhard Ziegler and Peter P Nawroth*

Department of Medicine I, University of Heidelberg, Bergheimer Straße 58, Heidelberg 69115, Germany

* Corresponding author. Tel.: (+49-6221) 568604; Fax: (+49-6221) 564101.

Objective: This is the first part of a bipartite review that summarizes the rising knowledge on the molecular mechanisms underlying the action of advanced glycation endproducts (AGEs) and their contribution to diabetic complications and vascular disease. While the first part presented here focusses on AGE formation, the second part will describe the AGE-protein/receptor interactions and their role in mediating AGE-dependent intracellular signalling. Results: Nonenzymatic glycation, in which reducing sugars are covalently attached to free amino groups and ultimately form AGEs, has been found to occur during normal aging and at accelerated rate in diabetes mellitus. Oxidation, accompanying glycation in vivo, further supports chemical modifications. AGE formation and protein crosslinking are irreversible processes that alter the structural and functional properties of proteins, lipid components and nucleic acids. AGE modifications do not only change the physicochemical properties of the afflicted molecules, but also induce cellular signalling, activation of transcription factors and subsequent gene expression in vitro and in vivo. Conclusions: AGEs elicit a wide range of cell-mediated responses that might contribute to the pathogenesis of diabetic complications, vascular and renal disease and Alzheimer's disease. Substances that inhibit AGE formation, reduce oxidative stress or destroy already formed crosslinks may limit the progression of disease and may offer new tools for therapeutic interventions in the therapy of AGEs mediated disease.

KEYWORDS Advanced glycation endproducts; Diabetes mellitus; Vascular disease


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. K. Takahashi, K. Liu, H. Wake, S. Mori, J. Zhang, R. Liu, T. Yoshino, and M. Nishibori
Prostaglandin E2 Inhibits Advanced Glycation End Product-Induced Adhesion Molecule Expression, Cytokine Production, and Lymphocyte Proliferation in Human Peripheral Blood Mononuclear Cells
J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 656 - 670.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
I. Sundl, J. M. Roob, A. Meinitzer, B. Tiran, G. Khoschsorur, B. Haditsch, H. Holzer, and B. M. Winklhofer-Roob
ANTIOXIDANT STATUS OF PATIENTS ON PERITONEAL DIALYSIS: ASSOCIATIONS WITH INFLAMMATION AND GLYCOXIDATIVE STRESS
Perit. Dial. Int., January 1, 2009; 29(1): 89 - 101.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Minetti, L. Agati, and W. Malorni
The microenvironment can shift erythrocytes from a friendly to a harmful behavior: Pathogenetic implications for vascular diseases
Cardiovasc Res, July 1, 2007; 75(1): 21 - 28.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
O. Kaloudi, G. Basta, F. Perfetto, F. Bartoli, A. Del Rosso, I. Miniati, M. L. Conforti, S. Generini, S. Guiducci, R. Abbate, et al.
Circulating levels of N{varepsilon}-(carboxymethyl)lysine are increased in systemic sclerosis
Rheumatology, March 1, 2007; 46(3): 412 - 416.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. A Gallicchio, E. A. McRobert, A. Tikoo, M. E. Cooper, and L. A. Bach
Advanced Glycation End Products Inhibit Tubulogenesis and Migration of Kidney Epithelial Cells in an Ezrin-Dependent Manner
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 414 - 421.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. H. Werstuck, M. I. Khan, G. Femia, A. J. Kim, V. Tedesco, B. Trigatti, and Y. Shi
Glucosamine-Induced Endoplasmic Reticulum Dysfunction Is Associated With Accelerated Atherosclerosis in a Hyperglycemic Mouse Model
Diabetes, January 1, 2006; 55(1): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Aragno, R. Mastrocola, C. Medana, F. Restivo, M. G. Catalano, N. Pons, O. Danni, and G. Boccuzzi
Up-Regulation of Advanced Glycated Products Receptors in the Brain of Diabetic Rats Is Prevented by Antioxidant Treatment
Endocrinology, December 1, 2005; 146(12): 5561 - 5567.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. M. Sengstock, P. V. Vaitkevicius, and M. A. Supiano
Arterial Stiffness Is Related to Insulin Resistance in Nondiabetic Hypertensive Older Adults
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2823 - 2827.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y.-T. Lin, Y.-Z. Tseng, and K.-C. Chang
Aminoguanidine Prevents Fructose-Induced Arterial Stiffening in Wistar Rats: Aortic Impedance Analysis
Experimental Biology and Medicine, November 1, 2004; 229(10): 1038 - 1045.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A Heidland, K Sebekova, A Frangiosa, L S De Santo, M Cirillo, F Rossi, M Cotrufo, A Perna, A Klassen, R Schinzel, et al.
Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation
Heart, November 1, 2004; 90(11): 1269 - 1274.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. Ziegler, C. G.H. Sohr, and J. Nourooz-Zadeh
Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy
Diabetes Care, September 1, 2004; 27(9): 2178 - 2183.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
K. MARTA, Z. TOMAS, P. PETR, S. PAVEL, B. MARTIN, S. JIRINA, P. KVETA, and K.-E. ROSEMARIE
ADVANCED GLYCATION END-PRODUCTS IN PATIENTS WITH CHRONIC ALCOHOL MISUSE
Alcohol Alcohol., July 1, 2004; 39(4): 316 - 320.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. V. Valencia, M. Mone, J. Zhang, M. Weetall, F. P. Buxton, and T. E. Hughes
Divergent Pathways of Gene Expression Are Activated by the RAGE Ligands S100b and AGE-BSA
Diabetes, March 1, 2004; 53(3): 743 - 751.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Roffi and E. J. Topol
Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes
Eur. Heart J., February 1, 2004; 25(3): 190 - 198.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Kalousova, S. Sulkova, L. Fialova, J. Soukupova, I. M. Malbohan, P. Spacek, M. Braun, L. Mikulikova, M. Fortova, M. Horejsi, et al.
Glycoxidation and inflammation in chronic haemodialysis patients
Nephrol. Dial. Transplant., December 1, 2003; 18(12): 2577 - 2581.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. K.M. Wong, A. I. Pettit, P. A. Quinn, S. C. Jennings, J. E. Davies, and L. L. Ng
Advanced Glycation End Products Stimulate an Enhanced Neutrophil Respiratory Burst Mediated Through the Activation of Cytosolic Phospholipase A2 and Generation of Arachidonic Acid
Circulation, October 14, 2003; 108(15): 1858 - 1864.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Culbertson, E. I. Vassilenko, L. D. Morrison, and Keith. U. Ingold
Paradoxical Impact of Antioxidants on Post-Amadori Glycoxidation: COUNTERINTUITIVE INCREASE IN THE YIELDS OF PENTOSIDINE AND N{epsilon}-CARBOXYMETHYLLYSINE USING A NOVEL MULTIFUNCTIONAL PYRIDOXAMINE DERIVATIVE
J. Biol. Chem., October 3, 2003; 278(40): 38384 - 38394.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. S. Shaw, A. M. Schmidt, A. K. Banes, X. Wang, D. M. Stern, and M. B. Marrero
S100B-RAGE-Mediated Augmentation of Angiotensin II-Induced Activation of JAK2 in Vascular Smooth Muscle Cells Is Dependent on PLD2
Diabetes, September 1, 2003; 52(9): 2381 - 2388.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Morcos, A. A.R. Sayed, A. Bierhaus, B. Yard, R. Waldherr, W. Merz, I. Kloeting, E. Schleicher, S. Mentz, R. F. Abd el Baki, et al.
Activation of Tubular Epithelial Cells in Diabetic Nephropathy
Diabetes, December 1, 2002; 51(12): 3532 - 3544.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Napoli, L. O. Lerman, F. de Nigris, J. Loscalzo, and L. J. Ignarro
Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells
J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1515 - 1522.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Endocr. Rev., October 1, 2002; 23(5): 599 - 622.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. K.M. Wong, A. I. Pettit, J. E. Davies, and L. L. Ng
Augmentation of the Neutrophil Respiratory Burst Through the Action of Advanced Glycation End Products: A Potential Contributor to Vascular Oxidant Stress
Diabetes, September 1, 2002; 51(9): 2846 - 2853.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Facchiano, A. Lentini, V. Fogliano, S. Mancarella, C. Rossi, A. Facchiano, and M. C. Capogrossi
Sugar-Induced Modification of Fibroblast Growth Factor 2 Reduces Its Angiogenic Activity in Vivo
Am. J. Pathol., August 1, 2002; 161(2): 531 - 541.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. H. Eckel, M. Wassef, A. Chait, B. Sobel, E. Barrett, G. King, M. Lopes-Virella, J. Reusch, N. Ruderman, G. Steiner, et al.
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: Pathogenesis of Atherosclerosis in Diabetes
Circulation, May 7, 2002; 105 (18): e138 - e143.
[Full Text] [PDF]


Home page
EndocrinologyHome page
S. M. Twigg, A. H. Joly, M. M. Chen, J. Tsubaki, H.-S. Kim, V. Hwa, Y. Oh, and R. G. Rosenfeld
Connective Tissue Growth Factor/IGF-Binding Protein-Related Protein-2 Is a Mediator in the Induction of Fibronectin by Advanced Glycosylation End-Products in Human Dermal Fibroblasts
Endocrinology, April 1, 2002; 143(4): 1260 - 1269.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. D.A. Stehouwer, M.-A. Gall, J. W.R. Twisk, E. Knudsen, J. J. Emeis, and H.-H. Parving
Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes: Progressive, Interrelated, and Independently Associated With Risk of Death
Diabetes, April 1, 2002; 51(4): 1157 - 1165.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. R. Bidasee, U. D. Dincer, and H. R. Besch Jr.
Ryanodine Receptor Dysfunction in Hearts of Streptozotocin-Induced Diabetic Rats
Mol. Pharmacol., December 1, 2001; 60(6): 1356 - 1364.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Bierhaus, S. Schiekofer, M. Schwaninger, M. Andrassy, P. M. Humpert, J. Chen, M. Hong, T. Luther, T. Henle, I. Kloting, et al.
Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-{kappa}B
Diabetes, December 1, 2001; 50(12): 2792 - 2808.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Xiang, R. Schinzel, A. Simm, G. Munch, K. Sebekova, M. Kasper, T. Niwa, C. Schmitz, and A. Heidland
Advanced glycation end products (AGEs)-induced expression of TGF-{beta}1 is suppressed by a protease in the tubule cell line LLC-PK1
Nephrol. Dial. Transplant., August 1, 2001; 16(8): 1562 - 1569.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. M. Twigg, M. M. Chen, A. H. Joly, S. D. Chakrapani, J. Tsubaki, H.-S. Kim, Y. Oh, and R. G. Rosenfeld
Advanced Glycosylation End Products Up-Regulate Connective Tissue Growth Factor (Insulin-Like Growth Factor-Binding Protein-Related Protein 2) in Human Fibroblasts: A Potential Mechanism for Expansion of Extracellular Matrix in Diabetes Mellitus
Endocrinology, May 1, 2001; 142(5): 1760 - 1769.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
N. Sakata, N. Uesugi, S. Takebayashi, R. Nagai, T. Jono, S. Horiuchi, M. Takeya, H. Itabe, T. Takano, T. Myint, et al.
Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis
Cardiovasc Res, February 1, 2001; 49(2): 466 - 475.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. E. Arking, A. Krebsova, M. Macek Sr., M. Macek Jr., A. Arking, I. S. Mian, L. Fried, A. Hamosh, S. Dey, I. McIntosh, et al.
Association of human aging with a functional variant of klotho
PNAS, January 22, 2002; 99(2): 856 - 861.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.